Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Newer Targets
Gene therapy/gene editing combo could offer hope for some genetic disorders
Newer Targets
Researchers at Rush University Medical Center Find That Injecting Influenza Vaccines…
Newer Targets
Research Reveals Promising New Avenues for Anemia Treatment
Newer Targets
Novel discovery in gene therapy to treat kidney diseases …
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Phase I
Atreca Announces First Patient Dosed in Phase 1b Clinical Trial of…
Clinical
Deciphera’s investigational GIST drug ripretinib granted priority review by FDA
Clinical
Eisai complies with FDA request to pull weight-loss drug Belviq from…
Clinical
FDA grants priority review to Bristol-Myers Squibb’s filing for liso-cel in…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
Acerus Announces Private Placement and Refinancing Transactions
Commercial
Following Clinical Hold and Trial Setback, Ipsen Takes $728 Million Hit…
Commercial
Indivior Full Year 2019 Results Now Available; Leadership Presentation Today
Deals
Sensorion Announces the Full Conversion of Sofinnova Partners Convertible Bonds Into…
Home
Commercial
Pricing
Pricing
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Pricing
Despite Calls to Lower Drug Prices, More than 600 Medications Saw Increases in January
Biospace News
-
February 7, 2020
Pricing
Medicare Could Save Billions If Allowed to Negotiate Insulin Prices ...
Pricing
XORTX Announces Re-Pricing of Private Placement
Pricing
Eli Lilly prices migraine therapy at $640 for pack of 8 pills ...
Pricing
Biocon plans to halve insulin prices ...
Pricing
Prices of MS Medications Keep Soaring ...
Firstwordpharma News
-
January 15, 2020
0
Pricing
Gilead, Biogen, GSK, Pfizer and Others Increase List Prices of Some...
Biospace News
-
January 2, 2020
0
Pricing
NPPA proposes to cap key diabetes drug four times higher than...
Firstwordpharma News
-
December 16, 2019
0
Pricing
Medicare Costs for Seniors Lowered in Senate Drug-Price Bill ...
Firstwordpharma News
-
December 6, 2019
0
Pricing
Industry executives: Profits drive rising prices for MS drugs
Firstwordpharma News
-
November 26, 2019
0
1
2
3
...
11
Page 1 of 11
- Advertisement -
MOST POPULAR
Helping Cancer Patients Navigate Clinical Trials
October 15, 2019
Biocon plans to halve insulin prices ...
January 17, 2020
CSL Behring, Pharming Group Embroiled in Intellectual Property Lawsuit
October 17, 2019
Abpro and NJCTTQ Enter Into Partnership for Development of Multiple Novel...
February 28, 2019
Load more
HOT NEWS
Deals
Kite and Kiniksa Pharmaceuticals Announce Clinical Collaboration Evaluating Investigational Combination of...
Approval
Regeneron’s Eylea granted expanded US approval for diabetic retinopathy
Clinical
Correvio Stock Trading Halted Today; FDA Advisory Committee Meeting To Discuss...
Deals
Vaccitech Oncology Limited Enters Collaboration with Cancer Research UK to Fund...
